Comparable stake leader
BAKER BROS. ADVISORS LP
SEC ownership of INCYTE CORP
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000879169.
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- INCY on Nasdaq
- Parsed ownership sources
-
13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BAKER BROS. ADVISORS LP
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BAKER BROS. ADVISORS LP
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000879169
- Issuer location
- Wilmington, DE
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of INCYTE CORP (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
50/50
Latest evidence
30 Jun 2026
13F
13D/G
3/4/5
Lead comparable stake: 16%
13D/G row: BAKER BROS. ADVISORS LP
Showing 1-8 of 50 holder rows.
Quick read
BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 16%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
BAKER BROS. ADVISORS LP
16%
BlackRock, Inc.
7.8%
VANGUARD CAPITAL MANAGEMENT LLC
6.3%
DODGE & COX
6.2%
STATE STREET CORP
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
13D/G
3/4/5
Company · Felix J. Baker · Director, 10%+ Owner
|
16%
from 13D/G
|
$3,487,217,729
30,762,330 shares
|
— | 30 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
7.8%
from 13D/G
|
$2,044,188,907
18,032,718 shares
|
— | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
13D/G
Company · Vanguard Capital Management
|
6.3%
from 13D/G
|
$1,249,713,401
11,024,289 shares
|
— | 30 Jun 2026 |
| DODGE & COX |
13F
13D/G
Company
|
6.2%
from 13D/G
|
$1,355,482,475
11,957,326 shares
|
— | 30 Jun 2026 |
| STATE STREET CORP |
13F
13D/G
Company · STATE STREET CORPORATION
|
5%
from 13D/G
|
$1,102,124,009
9,722,336 shares
|
— | 30 Jun 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
Company
|
3.9%
|
$883,198,076
7,791,091 shares
|
— | 30 Jun 2026 |
| AQR CAPITAL MANAGEMENT LLC |
13F
Company
|
2.7%
|
$603,177,347
5,320,901 shares
|
— | 30 Jun 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.4%
|
$536,515,860
4,750,735 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$55,613,823.
Buys
$0
Insiders: 0
Sells
$55,613,823
Insiders: 10
Net
-$55,613,823
Shares: -524,564
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 524,564
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 134,190 | $0 | $15,865,015 | -$15,865,015 |
| 3-6 | 0 | 52,334 | $0 | $4,984,494 | -$4,984,494 |
| 6-9 | 0 | 135,935 | $0 | $13,610,385 | -$13,610,385 |
| 9-12 | 0 | 202,105 | $0 | $21,153,930 | -$21,153,930 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 38 reporting-owner rows connected to INCYTE CORP. Open a relationship link for the CIK-to-CIK filing trail.
Rows
38
Largest Forms 3/4/5 holder
Baker Brothers Life Sciences LP
Net 12M change
-$55,613,824
Latest report
19 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Baker Brothers Life Sciences LP | Director, 10%+ Owner | $2,681,191,733 | Mixed | 30 Jun 2026 | ||
| 667, L.P. | Director, 10%+ Owner | $2,681,191,733 | Mixed | 30 Jun 2026 | ||
| Felix Baker | Director, 10%+ Owner | $2,681,191,733 | Mixed | 30 Jun 2026 | ||
| Baker Bros. Advisors (GP) LLC | Director, 10%+ Owner | $2,681,191,733 | Mixed | 30 Jun 2026 | ||
| Julian C. Baker | Director, 10%+ Owner | $2,681,191,733 | Mixed | 30 Jun 2026 | ||
| BAKER BROS. ADVISORS LP | Director, 10%+ Owner | $2,681,191,733 | Mixed | 30 Jun 2026 | ||
| Herve Hoppenot | Director | $31,601,850 | -$19,773,750 | -38% | Mixed | 08 Dec 2025 |
| Pablo J. Cagnoni | President, Global Head of R&D | $23,002,592 | -$11,304,512 | -33% | Filing P/S | 19 Aug 2026 |
| William Meury | Chief Executive Officer, Director | $20,759,503 | Median | 16 Jul 2026 | ||
| Christiana Stamoulis | EVP & Chief Financial Officer | $8,564,187 | Mixed | 14 Jul 2025 | ||
| Mohamed Khairie Issa | EVP, Head of U.S. Commercial | $8,138,907 | -$1,309,770 | -14% | Median | 16 Jul 2026 |
| Patrick A. Mayes | EVP & Chief Scientific Officer | $7,618,069 | -$6,562,988 | -46% | Filing P/S | 05 Aug 2026 |
| Paula J. Swain | EVP, Human Resources | $7,251,424 | Mixed | 14 Jul 2025 | ||
| Wenqing Yao | EVP, Head of Discovery Chem | $6,062,363 | Mixed | 02 Jul 2021 | ||
| Maria E. Pasquale | EVP & General Counsel | $4,288,026 | Mixed | 14 Jul 2023 | ||
| Lee Heeson | EVP, Head of Incyte Intl | $3,905,669 | -$289,017 | -6.9% | Mixed | 23 Jul 2026 |
| Dashyant Dhanak | EVP & Chief Scientific Officer | $3,626,532 | Mixed | 14 Jul 2023 | ||
| Steven H. Stein | CMO & Head of Late-Stage Dev. | $3,504,637 | -$7,856,770 | -69% | Median | 16 Jul 2026 |
| Michael James Morrissey | EVP, Head of Tech. Operations | $3,497,453 | -$5,675,002 | -62% | Mixed | 23 Jul 2026 |
| Sheila A. Denton | EVP & General Counsel | $2,772,740 | -$539,112 | -16% | Filing P/S | 17 Nov 2025 |
Recent insider transactions for INCYTE CORP
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Pablo J. Cagnoni | INCY | Common Stock | Sale | -5.57% | $1,356,174 | $125.56 | -10,801 | 183,200 | 19 Aug 2026 | Direct |
| Pablo J. Cagnoni | INCY | Common Stock | Sale | -5.27% | $1,296,792 | $120.04 | -10,803 | 194,001 | 12 Aug 2026 | Direct |
| Pablo J. Cagnoni | INCY | Common Stock | Sale | -4.94% | $1,305,422 | $122.69 | -10,640 | 204,804 | 05 Aug 2026 | Direct |
| Patrick A. Mayes | INCY | Common Stock | Sale | -3.47% | $273,646 | $123.99 | -2,207 | 61,441 | 05 Aug 2026 | Direct |
| Patrick A. Mayes | INCY | Common Stock | Options Exercise | 3.59% | 2,207 | 63,648 | 05 Aug 2026 | Direct | ||
| Patrick A. Mayes | INCY | Employee Stock Option (right to buy) | Options Exercise | -100% | -2,207 | 0 | 05 Aug 2026 | Direct | ||
| Patrick A. Mayes | INCY | Common Stock | Sale | -8.97% | $729,204 | $120.43 | -6,055 | 61,441 | 03 Aug 2026 | Direct |
| Patrick A. Mayes | INCY | Common Stock | Options Exercise | 9.85% | 6,055 | 67,496 | 03 Aug 2026 | Direct | ||
| Patrick A. Mayes | INCY | Employee Stock Option (right to buy) | Options Exercise | -100% | -6,055 | 0 | 03 Aug 2026 | Direct | ||
| Pablo J. Cagnoni | INCY | Common Stock | Sale | -6.87% | $1,901,794 | $119.70 | -15,888 | 215,444 | 31 Jul 2026 | Direct |
| Patrick A. Mayes | INCY | Common Stock | Sale | -40.5% | $5,005,173 | $119.46 | -41,899 | 61,441 | 31 Jul 2026 | Direct |
| Patrick A. Mayes | INCY | Common Stock | Options Exercise | 62.4% | 39,712 | 103,340 | 31 Jul 2026 | Direct | ||
| Patrick A. Mayes | INCY | Employee Stock Option (right to buy) | Options Exercise | -100% | -37,089 | 0 | 31 Jul 2026 | Direct | ||
| Michael James Morrissey | INCY | Performance Shares | Award | 8,999 | 8,999 | 23 Jul 2026 | Direct | |||
| Michael James Morrissey | INCY | Employee Stock Option (right to buy) | Award | 6,426 | 6,426 | 23 Jul 2026 | Direct | |||
| Lee Heeson | INCY | Performance Shares | Award | 13,498 | 13,498 | 23 Jul 2026 | Direct | |||
| Lee Heeson | INCY | Employee Stock Option (right to buy) | Award | 15,423 | 15,423 | 23 Jul 2026 | Direct | |||
| Thomas Tray | INCY | Common Stock | Award | 15% | 2,834 | 21,699 | 16 Jul 2026 | Direct | ||
| Thomas Tray | INCY | Employee Stock Option (right to buy) | Award | 4,079 | 4,079 | 16 Jul 2026 | Direct | |||
| Steven H. Stein | INCY | Common Stock | Award | 46.4% | 9,798 | 30,916 | 16 Jul 2026 | Direct | ||
| Steven H. Stein | INCY | Common Stock | Sale | -8.16% | $215,348 | $114.73 | -1,877 | 21,118 | 16 Jul 2026 | Direct |
| Steven H. Stein | INCY | Employee Stock Option (right to buy) | Award | 42,298 | 42,298 | 16 Jul 2026 | Direct | |||
| Steven H. Stein | INCY | Performance Shares | Award | 24,496 | 24,496 | 16 Jul 2026 | Direct | |||
| Patrick A. Mayes | INCY | Common Stock | Award | 10.2% | 5,916 | 63,628 | 16 Jul 2026 | Direct | ||
| Patrick A. Mayes | INCY | Employee Stock Option (right to buy) | Award | 25,538 | 25,538 | 16 Jul 2026 | Direct | |||
| Patrick A. Mayes | INCY | Performance Shares | Award | 14,790 | 14,790 | 16 Jul 2026 | Direct | |||
| Pablo J. Cagnoni | INCY | Common Stock | Award | 6.15% | 13,403 | 231,332 | 16 Jul 2026 | Direct | ||
| Pablo J. Cagnoni | INCY | Employee Stock Option (right to buy) | Award | 57,861 | 57,861 | 16 Jul 2026 | Direct | |||
| Pablo J. Cagnoni | INCY | Performance Shares | Award | 33,508 | 33,508 | 16 Jul 2026 | Direct | |||
| Mohamed Khairie Issa | INCY | Common Stock | Award | 12.3% | 7,857 | 71,797 | 16 Jul 2026 | Direct | ||
| Mohamed Khairie Issa | INCY | Common Stock | Sale | -1.68% | $125,706 | $115.01 | -1,093 | 63,940 | 16 Jul 2026 | Direct |
| Mohamed Khairie Issa | INCY | Employee Stock Option (right to buy) | Award | 33,918 | 33,918 | 16 Jul 2026 | Direct | |||
| Mohamed Khairie Issa | INCY | Performance Shares | Award | 19,643 | 19,643 | 16 Jul 2026 | Direct | |||
| Ramitpal K. Basi | INCY | Common Stock | Award | 76.7% | 4,991 | 11,497 | 16 Jul 2026 | Direct | ||
| Ramitpal K. Basi | INCY | Employee Stock Option (right to buy) | Award | 21,548 | 21,548 | 16 Jul 2026 | Direct | |||
| Ramitpal K. Basi | INCY | Performance Shares | Award | 12,479 | 12,479 | 16 Jul 2026 | Direct | |||
| David H. Gardner | INCY | Common Stock | Award | 78.4% | 7,395 | 16,824 | 16 Jul 2026 | Direct | ||
| David H. Gardner | INCY | Employee Stock Option (right to buy) | Award | 31,923 | 31,923 | 16 Jul 2026 | Direct | |||
| David H. Gardner | INCY | Performance Shares | Award | 18,487 | 18,487 | 16 Jul 2026 | Direct | |||
| Richard A. Hoffman | INCY | Common Stock | Award | 78.1% | 7,395 | 16,861 | 16 Jul 2026 | Direct | ||
| Richard A. Hoffman | INCY | Employee Stock Option (right to buy) | Award | 31,923 | 31,923 | 16 Jul 2026 | Direct | |||
| Richard A. Hoffman | INCY | Performance Shares | Award | 18,487 | 18,487 | 16 Jul 2026 | Direct | |||
| William Meury | INCY | Common Stock | Award | 17.2% | 26,807 | 183,129 | 16 Jul 2026 | Direct | ||
| William Meury | INCY | Employee Stock Option (right to buy) | Award | 77,148 | 77,148 | 16 Jul 2026 | Direct | |||
| William Meury | INCY | Performance Shares | Award | 80,421 | 80,421 | 16 Jul 2026 | Direct | |||
| Pablo J. Cagnoni | INCY | Common Stock | Tax liability | -2.22% | -4,950 | 217,929 | 15 Jul 2026 | Direct | ||
| Patrick A. Mayes | INCY | Common Stock | Tax liability | -2.55% | -1,512 | 57,712 | 15 Jul 2026 | Direct | ||
| Thomas Tray | INCY | Common Stock | Tax liability | -5.5% | -1,098 | 18,865 | 15 Jul 2026 | Direct | ||
| Steven H. Stein | INCY | Common Stock | Tax liability | -11.8% | -3,088 | 22,995 | 15 Jul 2026 | Direct | ||
| Steven H. Stein | INCY | Common Stock | Sale | -52% | $3,192,193 | $113.05 | -28,237 | 26,083 | 15 Jul 2026 | Direct |
* marks a reported price that did not pass the local price check.